Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
HOME > LATEST
LATEST
-
ARCHIVE Most Consumers Satisfied with OTC Drugs: JSMI Survey
September 22, 2003
-
ARCHIVE REGULATORY NEWS IN BRIEF
September 22, 2003
-
ARCHIVE HPB Report Recommends Ways to Revitalize OTC Drug Market
September 22, 2003
-
ARCHIVE Environment Ministry Studying Growing Problem of Home Care Waste
September 22, 2003
-
ARCHIVE Antacids Cost Twice as Much in Tokyo as New York: Korosho Survey
September 22, 2003
-
ARCHIVE Kowa Aiming for \12 Bil. in 1st-Year Sales for Livalo Tab.
September 22, 2003
-
ARCHIVE Korosho to Revise Hospital Accounting Rules
September 22, 2003
-
ARCHIVE Nearly 80% of Patients Want Pain Killers with Milder GI Effects: LCA-J Survey
September 22, 2003
-
ARCHIVE WEBSITE NEWS
September 15, 2003
-
ARCHIVE Nikko Memorial Hospital Trying Out New MR Visiting System
September 15, 2003
-
ARCHIVE New Waves in the Generic Drug Industry (2)
September 15, 2003
-
ARCHIVE National Med Facilities in Hokkaido Change Drug Procurement System
September 15, 2003
-
ARCHIVE Durotep Patch Showing Steady Growth
September 15, 2003
-
ARCHIVE Human Dry Dock Statistics for 2002 Show Results of Improved Lifestyles
September 15, 2003
-
ARCHIVE Draft GL for Rationalizing Elderly Medical Expenditure Announced
September 15, 2003
-
ARCHIVE MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 15, 2003
-
ARCHIVE METI Wants \3 Bil. to Support Health Services Industry
September 15, 2003
-
ARCHIVE NEW PRODUCTS
September 15, 2003
-
ARCHIVE Korosho to Submit Bill for "Basic Pharmaceutical Research Institute"
September 15, 2003
-
ARCHIVE Financial Results in 1st Quarter
September 15, 2003
ページ
Pharmaceutical companies are giving high marks to Japan’s drug pricing reform for FY2024. According to a survey conducted by Jiho, 51% of all respondents expressed a positive opinion of the reform, saying that they were “somewhat satisfied” with it. The…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…